Resource Logo
NLM AIDSLINE

MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells.




 

Cancer. 1999 Dec 25;87(6):390-4. Unique Identifier : AIDSLINE

BACKGROUND: Evaluation of effusion specimens for the presence of adenocarcinoma often is complicated by the presence of reactive mesothelial cells that can mimic adenocarcinoma. Ancillary studies, in particular immunohistochemistry, can be helpful in making this distinction. MOC-31 is an antibody that recently was reported to be useful in distinguishing adenocarcinoma from mesothelioma in tissue specimens. In this study we examined the utility of this antibody in pleural effusions. METHODS: Eighty-nine archival, formalin fixed, paraffin embedded cell blocks representing 59 adenocarcinomas, 12 other neoplasms (including 6 mesotheliomas), and 18 reactive effusions were retrieved. After protease digestion, recut slides were immunostained with the MOC-31 antibody utilizing a modified avidin-biotin complex technique. Only membrane-based reactivity was considered as positive. RESULTS: In two adenocarcinomas there was insufficient material remaining in the cell block. Among the 57 remaining cases, reactivity was observed in 54 cases. Reactivity also was observed in one of six mesotheliomas and one small cell carcinoma. The remaining cases, including all 18 reactive effusions, were nonreactive. In distinguishing adenocarcinoma from reactive mesothelial cells, the presence of MOC-31 reactivity was found to be 95% sensitive and 100% specific with a positive predictive value of 100% and a negative predictive value of 95%. CONCLUSIONS: MOC-31 is useful in differentiating between adenocarcinoma and reactive mesothelial cells in pleural effusion specimens. Cancer (Cancer Cytopathol) Copyright 1999 American Cancer Society.

JOURNAL ARTICLE Adenocarcinoma/*DIAGNOSIS/PATHOLOGY Antibodies, Monoclonal/*DIAGNOSTIC USE Antibodies, Neoplasm/*DIAGNOSTIC USE Carcinoma, Small Cell/DIAGNOSIS/PATHOLOGY Cell Membrane/ULTRASTRUCTURE Chromogenic Compounds/DIAGNOSTIC USE Diagnosis, Differential Dyes/*DIAGNOSTIC USE Endopeptidase K/DIAGNOSTIC USE Epithelial Cells/PATHOLOGY Fixatives Formaldehyde Hematoxylin/DIAGNOSTIC USE Human Immunoenzyme Techniques Immunohistochemistry Mesothelioma/DIAGNOSIS/PATHOLOGY Paraffin Embedding Pleural Effusion, Malignant/DIAGNOSIS/PATHOLOGY Predictive Value of Tests Sensitivity and Specificity 3,3'-Diaminobenzidine/DIAGNOSTIC USE



 




Information in this article was accurate in March 30, 2000. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.